Company Filing History:
2 out of 22 
1 out of 14,084 
1 out of 31 Years Active: 2020-2021
Title: Ehab Hamed: Innovator in Transdermal Delivery Systems
Introduction
Ehab Hamed is an accomplished inventor based in Lexington, MA, known for his significant contributions to the field of pharmaceutical formulations. With a total of two patents to his name, he has focused on innovations that enhance the delivery of therapeutically active compounds.
Latest Patents
Hamed's latest patents revolve around formulations of abaloparatide. These innovations include transdermal patches designed for the effective delivery of this compound, which is critical in treating conditions such as osteoporosis, osteopenia, and osteoarthritis. The patents detail methods of preparing these formulations and patches, while also outlining their applications in improving bone mineral density (BMD) and trabecular bone score (TBS). His work aims at providing effective treatments that can prevent or reduce bone fractures, thereby improving patient outcomes.
Career Highlights
Ehab Hamed has built an impressive career in the pharmaceutical industry. He has worked with leading companies such as Radius Health, Inc. and 3M Innovative Properties Company, where he has been at the forefront of research and development initiatives. His expertise in transdermal delivery systems has set him apart as a key figure in the innovation of therapeutic applications.
Collaborations
Throughout his career, Hamed has collaborated with notable professionals in the field, including Gary Hattersley and Alan Harris. These partnerships have contributed to fruitful innovations and have helped in advancing the research and development of transdermal delivery systems, particularly in relation to abaloparatide formulations.
Conclusion
Ehab Hamed's dedication to improving healthcare through innovative pharmaceutical solutions is exemplified in his patents and professional endeavors. With ongoing research and collaborations, he continues to pave the way toward more effective treatments for bone-related conditions. His work not only denotes a significant contribution to science but also reflects a commitment to enhancing the quality of life for patients.